InvestSMART

Underwood Capital Limited (ASX: UWC) - Share Price

Current share price for UWC : $0.051 0.001 (2%)+

Underwood Capital Limited (UWC, formerly Hygrovest Limited), an ASX-listed company, is an Australian-listed investment company which concentrates on producing capital growth for shareholders over the medium term from investments in listed and unlisted equities and debt securities.

UWC General Information +

ASX Code UWC
Website http://www.uwcl.com.au
Industry/Sector Pharmaceuticals
Market Cap ($M) 10
UWC Share Price $0.051
Day High $0.051
Day Low $0.050
Last Close $0.050
UWC Share Price Movement $0.00 ( 2% )
Prices as at 11:25, 11 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Underwood Capital Limited (UWC) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Underwood Capital Limited (UWC) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Underwood Capital Limited (UWC) price-sensitive announcements

UWC - Half Yearly Report and Accounts
Underwood Capital Limited's half-year report for the period ending 31 December 2025 highli
Underwood Capital Limited (UWC)
26 Feb 2026 | 9:37 AM
UWC - UWC Extension of OnMarket Share Buyback
Underwood Capital Limited, an Australian-listed investment company, announced the extensio
Underwood Capital Limited (UWC)
6 Oct 2025 | 1:38 PM
UWC - FY25 UWC Appendix 4E and Annual Report
The FY25 Appendix 4E and Annual Report for UWC (Underwood Capital Limited) highlights a ye
Underwood Capital Limited (UWC)
25 Aug 2025 | 8:10 AM
UWC - UWC Appendix 4D and financial statements
Underwood Capital Limited (formerly Hygrovest Limited) has reported its financial results
Underwood Capital Limited (UWC)
20 Feb 2025 | 1:10 PM

Underwood Capital Limited (UWC) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Underwood Capital Limited (UWC)
ORDINARY FULLY PAID
 Health Care $10 Notification of cessation of securities - UWC 10 Jun 2026 6:43PM $0.050 $0.051 risen by 2%
Underwood Capital Limited (UWC)
ORDINARY FULLY PAID
 Health Care $10 UWC Investment Portfolio Performance May 2026 10 Jun 2026 6:25PM $0.050 $0.051 risen by 2%
Underwood Capital Limited (UWC)
ORDINARY FULLY PAID
 Health Care $10 Update - Notification of buy-back - UWC 28 May 2026 6:22PM $0.050 $0.051 risen by 2%
Underwood Capital Limited (UWC)
ORDINARY FULLY PAID
 Health Care $10 Update - Notification of buy-back - UWC 26 May 2026 6:44PM $0.052 $0.051 fallen by 1.92%
Underwood Capital Limited (UWC)
ORDINARY FULLY PAID
 Health Care $10 Update - Notification of buy-back - UWC 26 May 2026 8:15AM $0.051 $0.051 fallen by 0%
Underwood Capital Limited (UWC)
ORDINARY FULLY PAID
 Health Care $10 Update - Notification of buy-back - UWC 25 May 2026 8:14AM $0.051 $0.051 fallen by 0%

UWC Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A $0.24 $0.10 -300.00% 39.30 0.00 0.00% 0.0%
2024A -$0.13 -$0.10 -96.60% 0.00 0.00 0.00% 0.0%
2023A -$3.98 -$1.70 -74.90% 0.00 0.00 0.00% 0.0%

UWC Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Clarity Pharmaceuticals Ltd (CU6) $802M 0.3002 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Neuren Pharmaceuticals Limited (NEU) $1,697M -0.7857 0.0743 1.2000 57.7138 53.7200 24.4182 0.00% 0.00% 0.00%
Underwood Capital Limited (UWC) $10M -3.0000 0.0000 0.0000 41.6667 0.0000 0.0000 0.00% 0.00% 0.00%

UWC Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.36 41.70 0.53 0.00
Market 0.36 12.90 1.15 0.70
Sector 0.42 28.00 2.53 2.04

UWC Directors

Name Position Start Date
Mr Jason Byrne Non-Executive Director 1 Aug 2023
Mr David Prescott Non-Executive Director 20 Mar 2023
Mr Warwick Sauer Non-Executive Director, Non-Executive Chairman 20 Mar 2023

Underwood Capital Limited (UWC) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
28 Apr 2026 SAUER, Warwick Buy Indirect Shares 222,281 $0.052 $11,490.280
27 Apr 2026 SAUER, Warwick Buy Indirect Shares 6,262 $0.051 $319.360
23 Apr 2026 SAUER, Warwick Buy Indirect Shares 151,063 $0.051 $7,704.950

See all changes in directors' interest & trades for Underwood Capital Limited (UWC) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

UWC Management

Name Position
James (Jim) Gerard Hallam Chief Financial Officer,Company Secretary

UWC Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Underwood Capital Limited (UWC). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
29,790,293 (14%) HD Capital Partners Pty Ltd
11,499,947 (5.50%) Bavaria Industries Group AG

UWC Calendar of Events

Date Event
25 February 2027 Report (Interim)
03 September 2026 Report (Annual)
24 August 2026 Report (Annual)
24 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.